Eli Lilly (NYSE:LLY) announced today that it received FDA approval and expanded labeling for its Lyumjev rapid-acting insulin. Indianapolis-based Eli Lilly’s Lyumjev (insulin lispro-aabc injection) 100 units/mL holds indication to improve glycemic control in adults with type 1 and type 2 diabetes, including administration via continuous subcutaneous insulin infusion (CSII) with an insulin pump. Get the […]
The security expert who hacked his own insulin pump revealed that the device came from Medtronic Inc. (NYSE:MDT), and accused the med-tech giant of ignoring his warnings.
Today the Natick, Mass.-based med-tech giant posted its official response to the hullabaloo, writing that it takes device information security very seriously but sees malicious medical device hacking as a very low threat.